


Research and pitch investors that are right for you with over 120K investors listed.

Browse our database of 40,000 angel investors, 69,000 VC Partners, VC funds, family offices and so much more!
Explore investor profiles, review past deals, and filter by industry, round size, location, and investment activity to find the best-fit investors for your startup.
Browse Investors
Connect with a growing community of active angel investors and VC partners who are reviewing startups and sourcing deals directly on Angels Partners.
Create your founder profile and get discovered by investors searching for startups in your industry, stage, and market.
Join the Community

Use your existing LinkedIn network to generate warm, high-quality investor introductions.
Our advanced LinkedIn Plugin analyzes your connections and identifies the strongest paths to the investors you want to reach.
Automate outreach, streamline follow-ups, and leverage your network more efficiently. All in just a few clicks!

Connect with other relevant founders inside the Angels Partners community and exchange introductions with angel investors and VC Partners.
Find founders in your industry, stage, and region who are also fundraising, and collaborate to accelerate your round.
Set your preferences, review profiles, and connect with vetted founders for mutual support, warm intros, and real conversations.
Join the Community


Send personalized emails to investors directly from the platform: track opens, clicks and engagement without switching tools.
Our AI helps you draft sharper, more relevant messages tailored to each investor’s profile, stage, and industry, improving relevance and outreach quality.
Automate follow-ups, manage outreach sequences, and spend more time building real relationships instead of admin.

Share your deck and materials securely and track opens, views, and investor engagement in real time.
See who is interested with detailed analytics, including view duration, click activity, and document access history.
Control access at any time, protect documents with email or password verification and revoke access instantly.
View Document Tools

We’re a team of founders and former VC operators based in New York City and London, bringing years of experience raising capital, scaling ventures, and supporting early-stage teams.
Having sat on both sides of the table, we know exactly what investors look for, and what founders need to get there. We built Angels Partners to give every founder access to the tools, data, and insights that make fundraising faster and more predictable.






We have designed Angels Partners to help you succeed. It's a one stop platform to research, reach and manage investors across the entire fundraising process.
Our pitch structure follows the format investors use to evaluate opportunities, helping you communicate clearly and stand out.
Match with investors based on sector, traction, geography, and deal history. Stop guessing who to contact, our filters simplify it.
Use our outreach tools to contact investors, automate follow-ups, and track engagement, so you book more meetings with less effort.
Gamers.Bet enables in-game wagering, which is a huge untapped revenue stream for studios and publishers.…

Wilmington, United States | Gaming (& eSports)
Gamers.bet powers real-money competitive gameplay inside mainstream video games, unlocking a massive revenue stream for studios and publishers. We address a $1 trillion market convergence by enabling native in-game wagering, a solution currently absent from the industry. Our model generates revenue by taking a percentage rake on every wager, which is shared with publishers to align incentives and drive adoption. Prize pools are created directly from entry fees paid by players; for example, 10 players paying $5 each creates a $50 prize pool, and Gamers.bet takes a fee (e.g., 10%). With millions of online matches played every day and highly scalable infrastructure, even conservative adoption rates (0.1%) can generate hundreds of millions in GTV.
OutDare offers a clean-label nicotine, energy, and CBD pouch system for focus, performance, and recovery.…

Sheridan, United States | Healthcare (& Wellness)
OutDare develops health-focused nicotine pouches with clean-label, plant-based formulations. Our DTC-native business model enables rapid market adaptation, leveraging e-commerce and performance marketing for scalable growth and low customer acquisition costs.
Electrogenics Labs provides FDA approved next-gen Radiation Dosimetry technology for both medical and non-medical markets.…
Delaware, United States | Medical Devices (& Hospital Services)
We plan to generate recurring revenue streams through consumables single-use MOSkin Dosimeters and software licenses. Our 'razor/blade model' ensures ongoing customer engagement, with additional revenue from MOSkin Hubs hardware sales and bundled three-year license fees covering Dosimeters, Hub, and SaaS fees. We project significant volume recovery over time, lowering COGS and increasing profitability .
VoluMetrix develops medical devices for non-invasive volume monitoring using venous waveform analysis.…

Nashville, United States | Medical Devices (& Hospital Services)
VoluMetrix is a platform technology company that has discovered how to process and draw clinical meaning from low-amplitude venous waveforms, creating a new vital sign for non-invasive volume monitoring1. We generate revenue through a "razor/razorblade" model by selling NIVA|HF bedside monitors and ClearIV disposables, supported by recurring revenue from wristband replacements and single-use sensors2. Our business extends beyond hardware; we aim to license our proprietary waveform analytics to strategic OEM partners for integration into existing infusion pumps, dialysis machines, and patient monitoring platforms3. Targeting a total market opportunity of $8B-$12B, our solutions address critical needs in heart failure management and vascular access, offering hospitals reduced readmissions and improved patient outcomes4444.
A SpaceTech venture pioneering secure, autonomous AI operations in orbit.…

Singapore, Singapore | Aerospace (& Defense)
Space Armour is building a secure AI platform for orbit, enabling intelligent, autonomous operations with cryptographic integrity and Zero Trust security. As the space economy surges toward a $1.8 trillion opportunity, critical infrastructure faces data overload, latency issues, and security vulnerabilities. Space Armour solves this by integrating a modular AI engine, an onboard blockchain node for verifiable audit trails, and a Zero Trust gateway directly into satellites and orbital platforms. The business model combines recurring revenue and high-value project fees. Core revenue comes from "In-Orbit AI-as-a-Service" via annual subscriptions and "Custom Deployments & Mission Engineering" charged on a project basis. In the interim, the company monetizes its QXLI AI Engine through partnerships and client projects, generating specific project and integration fees.
Deglace develops next-generation, more profitable vacuums than refurbished models with a platform model generating recurring revenue.…

Lille, France | Hardware (& Manufacturing)
Deglace develops next-generation, more profitable vacuums than refurbished models with a platform model generating recurring revenue. The company's vision is to expand its technology to all everyday appliances to redefine performance and durability on a global scale. The flagship product, Fraction, is the first vacuum cleaner with upgradable performance, featuring instant AI self-diagnosis and 100% modular, home-replaceable components. The revenue model is multi-faceted: sales of the New Fraction Vacuum Price at €499; a circular service for durability at home through the sale of new and refurbished modules priced between €19–€99; and AI self-diagnostic licensing to B2B customers. This model is designed to generate recurring revenue. Initial sales of 10,000 units at €499 will result in €5M in initial revenue with an additional €0.57M in recurring annual revenue. Deglace aims to tap into the high-growth global cordless vacuum market.
Whether you’re searching the Internet or fueling your business with data, Timpi delivers unfiltered access to the world's information without hidden agendas or algorithmic bias.
Auckland, New Zealand | A.I. (& Big Data)
Timpi generates revenue through a blend of privacy-first advertising, enterprise data services, and developer-focused APIs—anchored by our decentralized web index. Our diversified model supports scalable monetization across search, data and AI sectors.
Relationship-risk infrastructure for capital markets — mapping ownership, conflicts, and insider networks from regulatory filings in real-time.…

Vancouver, Canada | FinTech (& Financials services)
ACCREDITEX turns decades of fragmented insider filings into a real-time, explorable relationship-risk map—and sells access to it as a per-seat B2B SaaS platform for compliance, risk, and analyst teams. Pricing: • Individuals / small teams: $199/mo/seat • Compliance teams (6–20 seats): $899/mo/seat • Enterprise (21+ seats): $1,500/mo/seat We’ve proven demand with 50+ paying users and are now rolling out multi-seat collaboration to convert a strong pipeline (2 family offices, 3 exchanges, 1 regulator) into B2B contracts. Target model: $75K average ACV, 85–90% gross margins, land-and-expand (3–5 seats → 10–15 seats at maturity). Buyers: Compliance teams (KYC/AML), analysts, family offices, exchanges, and eventually banks & broker-dealers.
A health & performance lab offering advanced diagnostics for personalized medicine, fat loss & healthy aging to sports professionals & public.…

London, United Kingdom | Healthcare (& Wellness)
My Vital Metrics is a health and human performance lab providing advanced diagnostics traditionally reserved for elite athletes and medical specialists. The company delivers research-grade assessments across body composition, metabolism, blood biomarkers, movement, and DNA. As interest in healthy ageing, precision fitness, and personalized medicine accelerates, customers want actionable data rather than generic programmes. My Vital Metrics fills this gap with a comprehensive suite of assessments that guide targeted interventions for health, longevity, weight loss, and performance. The market opportunity is significant. Three converging sectors - personalised medicine (£16.14B, 9 percent CAGR), healthy ageing (£5.7B, 19.2 percent CAGR), and weight loss (£4.6B, 4.4 percent CAGR) - are expanding rapidly. In the UK and Europe, the market remains under-served, with few players offering the full suite of diagnostics. The business has first-mover advantage, strong brand leadership, and a model that scales efficiently across multiple sites. With consumer demand rising and professional sports partnerships growing, the company is positioned to dominate a category poised for multi-country expansion.
